-+ 0.00%
-+ 0.00%
-+ 0.00%

How $2.5b Note Sale Will Impact Akamai Stock Investors

Simply Wall St·11/16/2026 03:21:27
Listen to the news
  • Akamai Technologies recently completed multiple fixed income offerings totaling US$2.5 billion in convertible senior unsecured notes due 2028 and 2031, supported by a broad syndicate of co lead underwriters including global banks such as J.P. Morgan, BofA Securities and Goldman Sachs.
  • The fresh convertible funding coincides with rising capital needs for Akamai Technologies heavy cloud infrastructure buildout, which is already pressuring non GAAP operating margins as the business steps up data center and power related spending.
  • We will now look at how Akamai Technologies investment narrative around growth versus profitability could be affected by this large convertible funding.

Scan how Akamai Technologies’ heavy cloud buildout compares with other infrastructure hungry businesses by reviewing the hand picked 53 AI infrastructure stocks.

Akamai Technologies Investment Narrative Recap

To own Akamai Technologies today, you need to be comfortable with a capital heavy shift toward cloud infrastructure and security while the older delivery segment faces structural pressure. The analyst consensus narrative on Simply Wall St leans on strong contracted CIS demand and security as the growth engine. The latest US$2.5b of convertible notes, with a broad bank syndicate, mainly reinforces that spending plan rather than changing it.

In the near term, the main catalyst is execution on large AI infrastructure deals like Anthropic while keeping non GAAP operating margins near management targets despite high CapEx. The biggest risk is that these deployments do not reach the cash gross margin profile Akamai is targeting, leaving earnings and cash flow stretched against higher leverage.

The most relevant update here is Akamai Technologies issuing US$1.1b of 1% senior unsecured convertible notes due 2028 and another US$1.1b of 1% convertibles due 2031, both completed at 100% of principal under Rule 144A. Co lead underwriters now include J.P. Morgan Securities, BofA Securities, Morgan Stanley, Goldman Sachs, Citigroup, Barclays, RBC, HSBC, TD Securities and Scotia Capital.

For you as a shareholder, this sits directly against the CapEx heavy CIS build that underpins much of the long term narrative. Low coupon convertible funding can support the planned US$5.5b Anthropic related investment and roughly 40% of 2026 revenue going to CapEx, but it also introduces future dilution risk and increases reliance on high utilization and pricing in those AI infrastructure contracts.

Akamai Technologies' narrative projects US$8.1b revenue and US$973.7m earnings by 2029. This assumes 22.9% yearly revenue growth and requires earnings to rise by about US$585.8m from US$387.9m today.

Uncover why Akamai Technologies' fair value indicates a 53% potential upside to its current price, which could narrow quickly.

NasdaqGS:AKAM 1-Year Stock Price Chart
NasdaqGS:AKAM 1-Year Stock Price Chart

Exploring Other Perspectives

Some of the most pessimistic analysts focus on dilution risk. Before this new Akamai Technologies convertible funding and extra co lead underwriters, they were penciling in about US$6.0b of 2029 revenue and US$440.6m of earnings. That is far below the consensus path. Use this as a reminder that reasonable views can differ a lot, and that these pre news narratives may shift as the capital plan evolves.

Explore 3 other Akamai Technologies fair value estimates, including one that suggests it could be worth just $93.00.

The Verdict Is Yours

Don't just follow the ticker; dig into the data and build a conviction that's truly your own.

Looking for more investment ideas beyond Akamai Technologies?

If you want to pressure test Akamai Technologies against other opportunities, cast the net wider and see how different business models stack up on quality, income and risk using the Simply Wall St Screener.

  • If you want potential mispricing and quality in the same place, start with a focused set of 34 high quality undervalued stocks that already combine balance sheet strength with healthy cash generation.
  • For investors who care most about resilience and capital preservation, narrow your search to 29 resilient stocks with low risk scores that screen well on financial health and volatility.
  • If steadier income streams are the priority, concentrate on 6 dividend fortresses that pair a 5%+ yield with an emphasis on sustainability.